The poor performance report of top pharmaceutical companies on the fourth quarter… both in sales and profits

Published: 2015-01-27 14:12:03

Updated: 2015-01-27 14:12:03

It is analyzed performances of the top 4 listed pharmaceutical companies in sales were slowed down.

Declined market shares of the top pharmaceutical companies can be explained byadvances of mid-sized pharmaceutical companies.

Prescription expense shares of the top 5 pharmaceutical companies, such as Yuhan, Daewoong, Hanmi, Dong-A and Chong Kun Dang, were significantly decreased from 21% to 16...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.